- Home
- FTHM vs BFRI Comparison
FTHM vs BFRI Comparison
Compare FTHM & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTHM | BFRI |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4M | 12.2M |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FTHM | BFRI |
|---|---|---|
| Price | $0.20 | $0.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | ★ 1.6M | 259.0K |
| Earning Date | 11-10-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.71 | ★ 67.70 |
| EPS | N/A | N/A |
| Revenue | ★ $420,477,000.00 | $41,705,000.00 |
| Revenue This Year | $9.48 | $10.65 |
| Revenue Next Year | N/A | $15.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 25.45 | 11.75 |
| 52 Week Low | $0.18 | $0.57 |
| 52 Week High | $1.78 | $1.66 |
Technical Indicators
Market Signals| Indicator | FTHM | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 26.90 | 30.04 |
| Support Level | N/A | $0.77 |
| Resistance Level | $0.92 | $0.97 |
| Average True Range (ATR) | 0.02 | 0.06 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 51.24 | 8.43 |
Price Performance
Historical ComparisonAbout FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, and Software as a Service (SaaS) offerings to brokerages and agents by leveraging intelliAgent , proprietary cloud-based software. The Company's three operating and reportable segments: Real Estate Brokerage, Mortgage, and Title. The majority of revenue is from Real Estate Brokerage, which provides real estate brokerage services.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.